PA
RIG icon

PharVision Advisers’s Transocean RIG Stock Holding History

PharVision Advisers’s Portfolio RIG Stock Details RIG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Sell
14,965
-5,374
-26% -$33.6K 1.38% 40
2026
Q1 		$135K Buy
+20,339
New +$115K 1.37% 19

Other funds holding RIG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PharVision Advisers's RIG Position: Q2 2026 in Review

PharVision Advisers reduced its Transocean (RIG) stake by 26% in Q2 2026, selling an estimated $33.6K and leaving 14,965 shares worth $73.2K. The position accounts for 1.38% of the portfolio, ranked #40.

PharVision Advisers first reported a position in RIG in Q1 2026 and has held it in 2 quarters since. The position peaked at $135K in Q1 2026. 538 funds tracked by Wall St. Rank hold RIG as of Q2 2026.

  • PharVision Advisers held 14,965 shares of Transocean worth $73.2K as of Q2 2026.
  • PharVision Advisers sold 5,374 Transocean shares in Q2 2026, an estimated $33.6K.
  • Transocean made up 1.38% of PharVision Advisers's portfolio in Q2 2026, its #40 holding.
  • PharVision Advisers first reported a position in Transocean in Q1 2026 and has held it in 2 quarters since.
  • PharVision Advisers's Transocean position peaked at $135K in Q1 2026.
  • 538 funds tracked by Wall St. Rank held Transocean as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.